{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T08:58:07Z","timestamp":1783760287669,"version":"3.55.0"},"reference-count":65,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T00:00:00Z","timestamp":1657497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004612","name":"Funda\u00e7\u00e3o Arauc\u00e1ria","doi-asserted-by":"publisher","award":["Chamada P\u00fablica CP 09\/2016, Conv\u00eanio 001\/2017"],"award-info":[{"award-number":["Chamada P\u00fablica CP 09\/2016, Conv\u00eanio 001\/2017"]}],"id":[{"id":"10.13039\/501100004612","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Parkinson\u2019s disease (PD) is characterized by the loss of dopaminergic neurons in the substantia nigra, causing motor changes. In addition to motor symptoms, non-motor dysfunctions such as psychological, sensory and autonomic disorders are recorded. Manifestations related to the autonomic nervous system include the cardiovascular system, as postural hypotension, postprandial hypotension, and low blood pressure. One of the mediators involved is the nitric oxide (NO). In addition to the known roles such as vasodilator, neuromodulator, NO acts as an important mediator of the immune response, increasing the inflammatory response provoked by PD in central nervous system. The use of non-specific NOS inhibitors attenuated the neurodegenerative response in animal models of PD. However, the mechanisms by which NO contributes to neurodegeneration are still not well understood. The literature suggest that the contribution of NO occurs through its interaction with superoxides, products of oxidative stress, and blocking of the mitochondrial respiratory chain, resulting in neuronal death. Most studies involving Parkinsonism models have evaluated brain NO concentrations, with little data available on its peripheral action. Considering that studies that evaluated the involvement of NO in the neurodegeneration in PD, through NOS inhibitors administration, showed neuroprotection in rats, it has prompted new studies to assess the participation of NOS isoforms in cardiovascular changes induced by parkinsonism, and thus to envision new targets for the treatment of cardiovascular disorders in PD. The aim of this study was to conduct a literature review to assess available information on the involvement of nitric oxide (NO) in cardiovascular aspects of PD.<\/jats:p>","DOI":"10.3389\/fphar.2022.898797","type":"journal-article","created":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T07:26:17Z","timestamp":1657524377000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Nitric Oxide Involvement in Cardiovascular Dysfunctions of Parkinson Disease"],"prefix":"10.3389","volume":"13","author":[{"given":"Marli Cardoso","family":"Martins-Pinge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"de Jager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blenda Hyedra","family":"de Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena Oliveira","family":"Bezerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela Giovana","family":"Turini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phileno","family":"Pinge-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.neuint.2014.04.014","article-title":"The Role of Nitric Oxide on Visual-Evoked Potentials in MPTP-Induced Parkinsonism in Mice","volume":"72","author":"Aras","year":"2014","journal-title":"Neurochem. Int."},{"key":"B2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.neulet.2015.09.024","article-title":"Chemoreflex and Baroreflex Alterations in Parkinsonism Induced by 6-OHDA in Unanesthetized Rats","volume":"607","author":"Ariza","year":"","journal-title":"Neurosci. Lett."},{"key":"B3","doi-asserted-by":"publisher","first-page":"H250","DOI":"10.1152\/ajpheart.00406.2014","article-title":"Dysautonomias in Parkinson's Disease: Cardiovascular Changes and Autonomic Modulation in Conscious Rats after Infusion of Bilateral 6-OHDA in Substantia Nigra","volume":"308","author":"Ariza","year":"","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1590\/s1516-80342009000100021","article-title":"A\u00e7\u00e3o da levodopa e sua influ\u00eancia na voz e na fala de indiv\u00edduos com doen\u00e7a de Parkinson The action of levodopa and its influence on voice and speech of patients","volume":"14","author":"Azevedo","year":"2009","journal-title":"Rev. Soc. Bras. Fonoaudiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ene.14108","article-title":"Parkinson Disease","volume":"27","author":"Balestrino","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1179\/135100001101536436","article-title":"Role of Nitric Oxide in a Progressive Neurodegeneration Model of Parkinson's Disease in the Rat","volume":"6","author":"Barthwal","year":"2001","journal-title":"Redox Rep."},{"key":"B7","doi-asserted-by":"publisher","first-page":"S124","DOI":"10.1016\/j.parkreldis.2008.04.015","article-title":"The 6-hydroxydopamine Model: News from the Past","volume":"14","author":"Blandini","year":"2008","journal-title":"Park. Relat. Disord."},{"key":"B8","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0301-0082(01)00003-X","article-title":"Molecular Pathways Involved in the Neurotoxicity of 6-OHDA, Dopamine and MPTP: Contribution to the Apoptotic Theory in Parkinson's Disease","volume":"65","author":"Blum","year":"2001","journal-title":"Prog. Neurobiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.freeradbiomed.2010.12.026","article-title":"Neuroprotection by the Selective iNOS Inhibitor GW274150 in a Model of Parkinson Disease","volume":"50","author":"Broom","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1007\/s10072-016-2663-1","article-title":"Oxidative and Nitrosative Stress in Serum of Patients with Parkinson's Disease","volume":"37","author":"\u00c7ubuk\u00e7u","year":"2016","journal-title":"Neurol. Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"13488","DOI":"10.3390\/ijms222413488","article-title":"Cardiac Changes in Parkinson's Disease: Lessons from Clinical and Experimental Evidence","volume":"22","author":"Cuenca-Bermejo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.brainres.2013.10.011","article-title":"Alterations in the Expression of nNOS in the Substantia Nigra and Subthalamic Nucleus of 6-OHDA-Lesioned Rats: The Effects of Chronic Treatment with L-DOPA and the Nitric Oxide Donor, Molsidomine","volume":"1541","author":"Czarnecka","year":"2013","journal-title":"Brain Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's Disease: Mechanisms and Models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"B14","doi-asserted-by":"publisher","first-page":"118259","DOI":"10.1016\/j.lfs.2020.118259","article-title":"Cardiovascular Evaluation of Female Rats with 6-OHDA-Induced Parkinsonism: Possible Protection by Ovarian Hormones and Participation of Nitric Oxide","volume":"259","author":"de Campos","year":"2020","journal-title":"Life Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.lfs.2018.05.017","article-title":"Nitric Oxide Alterations in Cardiovascular System of Rats with Parkinsonism Induced by 6-OHDA and Submitted to Previous Exercise","volume":"204","author":"de Jager","year":"2018","journal-title":"Life Sci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","article-title":"Epidemiology of Parkinson's Disease","volume":"5","author":"de Lau","year":"2006","journal-title":"Lancet Neurology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"797","DOI":"10.2165\/11317750-000000000-00000","article-title":"The Effect of Physical Exercise on Endothelial Function","volume":"39","author":"Di Francescomarino","year":"2009","journal-title":"Sports Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1046\/j.1471-4159.1996.67062443.x","article-title":"Role of Nitric Oxide in Methamphetamine Neurotoxicity: Protection by 7-nitroindazole, an Inhibitor of Neuronal Nitric Oxide Synthase","volume":"67","author":"Di Monte","year":"1996","journal-title":"J. Neurochem."},{"key":"B19","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3233\/JPD-130230","article-title":"The Role of Oxidative Stress in Parkinson's Disease","volume":"3","author":"Dias","year":"2013","journal-title":"J. Park. Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1007\/s12264-011-1530-6","article-title":"Nitric Oxide in Neurodegeneration: Potential Benefits of Non-steroidal Anti-inflammatories","volume":"27","author":"Doherty","year":"2011","journal-title":"Neurosci. Bull."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1111\/j.1476-5381.2011.01426.x","article-title":"Animal Models of Parkinson's Disease: a Source of Novel Treatments and Clues to the Cause of the Disease","volume":"164","author":"Duty","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.brainres.2016.12.008","article-title":"Cardiovascular Dysfunction Associated with Neurodegeneration in an Experimental Model of Parkinson's Disease","volume":"1657","author":"Falquetto","year":"2017","journal-title":"Brain Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/mds.27316","article-title":"Nigrostriatal Dopamine Transporter Availability in Early Parkinson's Disease","volume":"33","author":"Fazio","year":"2018","journal-title":"Mov. Disord."},{"key":"B24","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1093\/eurheartj\/ehr304","article-title":"Nitric Oxide Synthases: Regulation and Function","volume":"33","author":"Forstermann","year":"2012","journal-title":"Eur. Heart J."},{"key":"B25","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.autneu.2017.04.002.Autonomic","article-title":"Autonomic and Electrocardiographic Findings in Parkinson's Disease","volume":"205","author":"Gibbons","year":"2017","journal-title":"Aut. Neurosci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"S91","DOI":"10.3949\/ccjm.74.Suppl_1.S91","article-title":"Cardiac Denervation in Patients with Parkinson Disease","volume":"74","author":"Goldstein","year":"2007","journal-title":"Clevel. Clin. J. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1113\/jphysiol.2004.068197","article-title":"Effect of Exercise Training on Endothelium-Derived Nitric Oxide Function in Humans","volume":"561","author":"Green","year":"2004","journal-title":"J. Physiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"S183","DOI":"10.1016\/S1353-8020(11)70057-8","article-title":"Animal Models of Parkinson's Disease","volume":"18","author":"Jackson-Lewis","year":"2012","journal-title":"Park. Relat. Disord."},{"key":"B29","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.nbd.2011.10.025","article-title":"Cardiovascular Dysautonomia in Parkinson Disease: From Pathophysiology to Pathogenesis","volume":"46","author":"Jain","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.brainres.2008.12.081","article-title":"Age- and Sex-Differences in the Nitric Oxide Synthase Expression and Dopamine Concentration in the Murine Model of Parkinson's Disease Induced by 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine","volume":"1261","author":"Joniec","year":"2009","journal-title":"Brain Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1093\/hmg\/ddg009","article-title":"Association between Parkinson's Disease and Polymorphisms in the nNOS and iNOS Genes in a Community-Based Case-Control Study","volume":"12","author":"Levecque","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1038\/70978","article-title":"Inducible Nitric Oxide Synthase Stimulates Dopaminergic Neurodegeneration in the MPTP Model of Parkinson Disease","volume":"5","author":"Liberatore","year":"1999","journal-title":"Nat. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12640-020-00182-4","article-title":"MPTP-induced Impairment of Cardiovascular Function","volume":"38","author":"Liu","year":"2020","journal-title":"Neurotox. Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1042\/bse0420119","article-title":"Vascular Nitric Oxide: Effects of Physical Activity, Importance for Health","volume":"42","author":"McAllister","year":"2006","journal-title":"Essays Biochem."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/15353702062310090110.3181\/00379727-211-43950a","article-title":"Nitric Oxide and Cyclic GMP Signaling","volume":"211","author":"McDonald","year":"1996","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s10286-018-00584-7","article-title":"Autonomic Dysfunction in Parkinson Disease and Animal Models","volume":"29","author":"Metzger","year":"2019","journal-title":"Clin. Auton. Res."},{"key":"B37","first-page":"25","article-title":"Disautonomia na Doen\u00e7a de Parkinson, Revis\u00e3o da literatura","volume":"47","author":"Nicaretta","year":"2011","journal-title":"Rev. Bras. Neurol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"108877","DOI":"10.1016\/j.abb.2021.108877","article-title":"Nitric Oxide and Dopamine Metabolism Converge via Mitochondrial Dysfunction in the Mechanisms of Neurodegeneration in Parkinson's Disease","volume":"704","author":"Nunes","year":"2021","journal-title":"Arch. Biochem. Biophys."},{"key":"B39","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3389\/fphar.2020.00435","article-title":"The Noradrenergic System in Parkinson's Disease","volume":"11","author":"Paredes-Rodriguez","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B40","first-page":"15","article-title":"Fatores de risco na doen\u00e7a de Parkinson","volume":"23","author":"Pereira","year":"2010","journal-title":"Acta Med. Port."},{"key":"B41","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1152\/physiol.00034.2015","article-title":"Neural Control of Walking in People with Parkinsonism","volume":"31","author":"Peterson","year":"2016","journal-title":"Physiol. (Bethesda)"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/mds.25945","article-title":"The Prevalence of Parkinson's Disease: a Systematic Review and Meta-Analysis","volume":"29","author":"Pringsheim","year":"2014","journal-title":"Mov. Disord."},{"key":"B43","doi-asserted-by":"publisher","first-page":"4565","DOI":"10.1073\/pnas.93.10.4565","article-title":"Role of Neuronal Nitric Oxide in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)-induced Dopaminergic Neurotoxicity","volume":"93","author":"Przedborski","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1002\/mds.21127","article-title":"Age at Menopause Predicts Age at Onset of Parkinson's Disease","volume":"21","author":"Ragonese","year":"2006","journal-title":"Mov. Disord."},{"key":"B45","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.pharmthera.2013.07.004","article-title":"Nitric Oxide Synthase Inhibition and Oxidative Stress in Cardiovascular Diseases: Possible Therapeutic Targets?","volume":"140","author":"Rochette","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/S1474-4422(09)70293-5","article-title":"Initial Clinical Manifestations of Parkinson's Disease: Features and Pathophysiological Mechanisms","volume":"8","author":"Rodriguez-Oroz","year":"2009","journal-title":"Lancet Neurol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1152\/jn.00548.2020","article-title":"Baroreflex Dysfunction in Parkinson's Disease: Integration of Central and Peripheral Mechanisms","volume":"125","author":"Sabino-Carvalho","year":"2021","journal-title":"J. Neurophysiol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.parkreldis.2016.09.027","article-title":"Heart Rate Variability in Patients with Essential Tremor: A Cross Sectional Study","volume":"33","author":"Salsone","year":"2016","journal-title":"Park. Relat. Disord."},{"key":"B49","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nrneurol.2010.52","article-title":"Molecular and Clinical Prodrome of Parkinson Disease: Implications for Treatment","volume":"6","author":"Schapira","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrn.2017.62","article-title":"Non-motor Features of Parkinson Disease","volume":"18","author":"Schapira","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"B51","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1046\/j.1471-4159.1995.64020936.x","article-title":"Inhibition of Neuronal Nitric Oxide Synthase by 7-Nitroindazole Protects against MPTP-Induced Neurotoxicity in Mice","volume":"64","author":"Schulz","year":"1995","journal-title":"J. Neurochem."},{"key":"B52","first-page":"365","article-title":"Doen\u00e7a de Parkinson: tratamento medicamentoso e seu impacto na reabilita\u00e7\u00e3o de seus portadores","volume":"25","author":"Scorza","year":"2001","journal-title":"Mundo Sa\u00fade"},{"key":"B53","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/S1474-4422(21)00219-2","article-title":"Parkinson's Disease outside the Brain: Targeting the Autonomic Nervous System","volume":"20","author":"Sharabi","year":"2021","journal-title":"Lancet Neurol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s007020050171","article-title":"Parkinson's Disease: a Major Hypokinetic Basal Ganglia Disorder","volume":"106","author":"Sian","year":"1999","journal-title":"J. Neural Transm. (Vienna)"},{"key":"B55","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.lfs.2015.01.032","article-title":"Cardiovascular and Autonomic Alterations in Rats with Parkinsonism Induced by 6-OHDA and Treated with L-DOPA","volume":"127","author":"Silva","year":"2015","journal-title":"Life Sci."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cger.2019.08.002","article-title":"Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology","volume":"36","author":"Simon","year":"2020","journal-title":"Clin. Geriatr. Med."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1007\/s00702-015-1393-5","article-title":"Heart Rate Variability Shows Different Cardiovascular Modulation in Parkinson's Disease Patients with Tremor Dominant Subtype Compared to Those with Akinetic Rigid Dominant Subtype","volume":"122","author":"Solla","year":"2015","journal-title":"J. Neural Transm. (Vienna)"},{"key":"B58","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.autneu.2013.08.067","article-title":"Reduced Sympathetic Activity in Idiopathic Rapid-Eye-Movement Sleep Behavior Disorder and Parkinson's Disease","volume":"179","author":"Sorensen","year":"2013","journal-title":"Auton. Neurosci."},{"key":"B59","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jns.2016.09.036","article-title":"Cardiovascular Dysfunction in Untreated Parkinson's Disease: A Multi-Modality Assessment","volume":"370","author":"Strano","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"B60","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.ncl.2013.04.013","article-title":"Nonmotor Symptoms in Parkinson's Disease: Expanding the View of Parkinson's Disease beyond a Pure Motor, Pure Dopaminergic problemNeurologic Clinics","volume":"31","author":"Sung","year":"2013","journal-title":"Neurol. Clin."},{"key":"B61","doi-asserted-by":"crossref","first-page":"201","DOI":"10.34024\/rnc.2005.v13.8794","article-title":"Etiopatogenia da doen\u00e7a de Parkinson","volume":"13","author":"Teive","year":"2005","journal-title":"Rev. Neurocienc."},{"key":"B62","first-page":"17","article-title":"Neuroprote\u00e7\u00e3o: fatos, mitos e quimeras","volume-title":"Teive HAG. Doen\u00e7a de Parkinson: estrat\u00e9gias atuais de tratamento","author":"Teive","year":"2006"},{"key":"B63","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1080\/1521654032000114320","article-title":"Nitric Oxide and Reactive Oxygen Species in Parkinson's Disease","volume":"55","author":"Tieu","year":"2003","journal-title":"IUBMB Life"},{"key":"B64","doi-asserted-by":"publisher","first-page":"e13264","DOI":"10.1111\/apha.13264","article-title":"Glutamate and GABA Neurotransmission Are Increased in Paraventricular Nucleus of Hypothalamus in Rats Induced to 6-OHDA Parkinsonism: Involvement of nNOS","volume":"226","author":"Turossi Amorim","year":"2019","journal-title":"Acta Physiol. (Oxf)"},{"key":"B65","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1590\/S0102-76382009000200018","article-title":"Basic Notions of Heart Rate Variability and its Clinical Applicability","volume":"24","author":"Vanderlei","year":"2009","journal-title":"Rev. Bras. Cir. Cardiovasc"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.898797\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T07:26:23Z","timestamp":1657524383000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.898797\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,11]]},"references-count":65,"alternative-id":["10.3389\/fphar.2022.898797"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.898797","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,11]]},"article-number":"898797"}}